Thoracic SurgeryDr. Shaiwal KhandelwalThoracic Surgery

Director, Thoracic Surgery, Max Healthcare (Saket, Gurugram)

Part 7 of 9 in Thoracic Surgery: Basics to Robotics

Thoracic Emergencies: Chylothorax with ICG Guidance and Boerhaave Syndrome

August 24, 2025

In one especially complex case, a patient had tuberculous empyema on the right side and chylothorax on the left, requiring ligation of the thoracic duct just above the diaphragm. In the presence of dense inflammatory tissue, the duct itself was difficult to visualise directly, so the patient was given pre-operative fat and indocyanine green (ICG) dye injected into the inguinal lymph nodes; under the robotic camera's infrared light, the dye highlighted the thoracic duct clearly enough to localise and ligate it precisely, followed by routine decortication on the right side. The patient had no recurrence of chylothorax and was discharged after four days.

Boerhaave syndrome: a dangerous, easily missed diagnosis

Boerhaave syndrome, spontaneous oesophageal rupture caused by retching or forceful coughing against a closed upper glottis, typically ruptures at the lower oesophagus, usually on the left, and can present as a left-sided empyema. It is a very dangerous condition that must be promptly identified and addressed. One patient was managed with endoscopy and stenting first to control the leak, followed by drainage and debridement of the resulting mediastinal collection; the patient recovered well and was discharged after seven days, with the stent removed six weeks later.

The common thread across thoracic emergencies

Both cases illustrate the same principle that runs through Dr. Khandelwal's broader practice: even genuinely rare, high-stakes thoracic emergencies can be managed with minimally invasive technique and precise, staged intervention, provided the diagnosis is made promptly and the right combination of endoscopic and surgical tools is brought to bear.

This article is based on a Jivo Masterclass session conducted by Dr. Shaiwal Khandelwal, Director, Thoracic Surgery, Max Healthcare. The article has been summarised with the assistance of an AI tool from the original masterclass recording. Watch the full Masterclass recording

Looking for a thoracic surgery consultation or a second opinion? Get in touch with the Jivo team

This guide is based on a live Jivo Masterclass — Dr. Shaiwal Khandelwal taught doctors across Africa on August 24, 2025.

FROM THE LIVE Q&A

DR

Dr. Isaya (Nigeria)

Approximately how many thoracic surgery patients from Africa have you treated, given that you practise in New Delhi?

SK

Dr. Shaiwal Khandelwal

A large number of patients from various African countries have been treated, most commonly for bronchiectasis and various tumours of the lung and chest cavity, even without ever having personally visited Africa. For heart transplantation specifically, deceased-donor transplant is not possible for international patients under Indian law, so the more common referral for advanced heart failure from abroad is for an LVAD (left ventricular assist device), which has very good outcomes and has itself reduced overall demand for heart transplant.

See all 8 questions from this masterclass →

Book a Consultation with Dr. Shaiwal Khandelwal

Book on WhatsApp

Or message us on WhatsApp: +91 98182 98669

Frequently Asked Questions

What are the success rates of lung transplantation?

Deceased-donor lung transplantation is not possible for international patients in India under current law, but in general, outcomes vary significantly by the underlying pathology, results are good for pulmonary hypertension, while outcomes for cystic fibrosis, bronchiectasis and other conditions vary by the individual disease process rather than following one single success rate.

How do you control fibrosis, meaning adhesions in the lung, following resection of empyema, and is lung transplantation possible after pulmonary tuberculosis?

After empyema surgery in young patients, both a visceral and parietal decortication are performed, and dense adhesions do form afterward, that is simply the nature of the disease and the aim of surgery is to release the lung and prevent fibrothorax, not to avoid adhesions altogether. Lung transplantation after pulmonary tuberculosis is very challenging, particularly if the patient has already developed fibrothorax; a unilateral transplant may be possible in some cases, but it depends entirely on the individual patient and no generalised statement can be made. Deceased-donor lung transplant is also not available to international patients under Indian law, which permits only living donors.

How do you avoid the laryngeal nerves while operating in the thoracic region using robotic tools, and is the robot able to resect tumours completely when they are closely related to sensitive areas like the laryngeal nerves?

The robotic platform's vision is excellent, so nerves that are difficult to identify by standard VATS are very clearly seen with the robotic system, and it also allows much finer dissection. These sensitive structures are therefore better identified and better protected specifically because of the robotic system's magnified 3D vision and precise instrument control.

Can you elaborate more on hyperhidrosis surgery, specifically how patients are selected and how the procedure is performed?

Surgery should never be offered to every patient with hyperhidrosis; a detailed assessment is required first, and all non-surgical options, oral medication, local treatment, creams, and Botox, should be exhausted first. Surgery is reserved only for high-grade hyperhidrosis where the hands are literally dripping, since every form of surgery carries some side effects, and the benefit of dry hands has to be weighed against them. Patient selection and precise technique matter more than the surgery itself: robotic assistance allows accurate identification of the ganglia, which is very difficult by standard VATS, and Dr. Khandelwal's own technique of setting the sympathetic chain close to the third ganglion with a grey ramicotomy at that level has produced good results with fewer side effects than older, less precise approaches.

Is it possible to invent artificial lungs, and is there any research going on for this? Also, how far away is xenotransplantation, using organs harvested from animals?

Devices like Novalung or ECMO are sometimes loosely called artificial lungs, but these are only a transition to tide a patient over, not a permanent solution. Xenotransplantation for lungs is not a reality and is still limited to animal labs, with no near-term prospect of harvesting an animal lung for human transplantation. What is genuinely advancing is ex vivo lung perfusion (EVLP), where a harvested lung is brought to a lab and optimised before transplant, this has meaningfully increased organ utilisation and allows transplant surgery to be done electively rather than only at odd hours, though it remains expensive even in Western countries.

How is a difficult-to-visualise thoracic duct located during chylothorax surgery?

By injecting indocyanine green (ICG) dye into the inguinal lymph nodes pre-operatively; under the robotic camera's infrared light, the dye highlights the thoracic duct clearly enough to localise and ligate it precisely, even in dense inflammatory tissue.

What is Boerhaave syndrome and how is it managed?

Spontaneous oesophageal rupture from forceful retching or coughing, typically at the lower oesophagus on the left side, which can present as empyema. It is managed with endoscopy and stenting to control the leak first, followed by drainage and debridement of the mediastinal collection.

Need Expert Medical Guidance?

Connect with leading specialists through the Jivo Healthcare network for personalized advice.

Get Expert Opinion